Thermo Fisher Scientific (TMO) Tops Q2 EPS by 11c
Tweet
Share
E-mail
Get Alerts TMO Hot Sheet
Price: $605.07 -1.42%
EPS Growth %: +10.7%
Financial Fact:
Cost of product revenues: 2.02B
Today's EPS Names:
VIVO, BIOX, PMCB, More
EPS Growth %: +10.7%
Financial Fact:
Cost of product revenues: 2.02B
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Thermo Fisher Scientific (NYSE: TMO) reported Q2 EPS of $5.60, $0.11 better than the analyst estimate of $5.49. Revenue for the quarter came in at $9.27 billion versus the consensus estimate of $8.77 billion.
GUIDANCE:
Thermo Fisher Scientific sees FY2021 EPS of $22.07, versus the consensus of $22.12. Thermo Fisher Scientific sees FY2021 revenue of $35.9 billion, versus the consensus of $35.66 billion.
For earnings history and earnings-related data on Thermo Fisher Scientific (TMO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- United Natural Foods (UNFI) Tops Q4 EPS by 8c ; Offers Guidance
- HSBC lifts S&P 500 year-end target
- Freeport-McMoRan shares surge as copper hits record $14,694/ton
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
